Cargando…

Prevalence of Mental Disorders and Impact on Quality of Life in Patients With Pulmonary Arterial Hypertension

Objective: Mental health may affect the quality of life (QoL) in patients with pulmonary arterial hypertension (PAH). However, mental disorders have not been systematically assessed in these patients. We examined the prevalence of mental disorders using structured interviews and determined their imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olsson, Karen M., Meltendorf, Tanja, Fuge, Jan, Kamp, Jan C., Park, Da-Hee, Richter, Manuel J., Gall, Henning, Ghofrani, Hossein A., Ferrari, Pisana, Schmiedel, Ralf, Kulla, Hans-Dieter, Heitland, Ivo, Lepsy, Nicole, Dering, Madelaine-Rachel, Hoeper, Marius M., Kahl, Kai G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200462/ https://www.ncbi.nlm.nih.gov/pubmed/34135787 http://dx.doi.org/10.3389/fpsyt.2021.667602

Ejemplares similares

Childhood Maltreatment, Mental Well-Being, and Healthy Lifestyle in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Lepsy, Nicole, et al.
Publicado: (2022)

Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension
por: Dering, Madelaine-Rachel, et al.
Publicado: (2022)

Metacognitions in Patients With Frequent Mental Disorders After Diagnosis of Pulmonary Arterial Hypertension
por: Caldarone, Flora, et al.
Publicado: (2022)

Childhood Trauma in Patients With PAH—Prevalence, Impact on QoL, and Mental Health—A Preliminary Report
por: Park, Da-Hee, et al.
Publicado: (2022)

Impact of SARS-CoV-2-Pandemic on Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension
por: Park, Da Hee, et al.
Publicado: (2021)

Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial Hypertension
por: Park, Da-Hee, et al.
Publicado: (2022)

Impact of Pulmonary Arterial Hypertension on Employment, Work Productivity, and Quality of Life - Results of a Cross-Sectional Multi-Center Study
por: Fuge, Jan, et al.
Publicado: (2022)

Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension
por: Gall, Henning, et al.
Publicado: (2021)

Metacognitive Therapy for Adjustment Disorder in a Patient With Newly Diagnosed Pulmonary Arterial Hypertension: A Case Report
por: Winter, Lotta, et al.
Publicado: (2020)

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2020)

Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
por: Kamp, Jan C., et al.
Publicado: (2021)

Capillary pCO(2) helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction
por: Olsson, Karen M, et al.
Publicado: (2015)

Acute hemodynamic effects of adaptive servoventilation in patients with pre-capillary and post-capillary pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2015)

Metacognitive Short-Term Intervention in Patients With Mental Disorders Following Cardiovascular Events
por: Gebhardt, Philippa, et al.
Publicado: (2022)

Thin Air Resulting in High Pressure: Mountain Sickness and Hypoxia-Induced Pulmonary Hypertension
por: Grimminger, Jan, et al.
Publicado: (2017)

Secondary Traumatic Stress, Mental State, and Work Ability in Nurses—Results of a Psychological Risk Assessment at a University Hospital
por: Bock, Christian, et al.
Publicado: (2020)

C-reactive protein and procalcitonin for antimicrobial stewardship in COVID-19
por: Pink, Isabell, et al.
Publicado: (2021)

Medical management of chronic thromboembolic pulmonary hypertension
por: Pepke-Zaba, Joanna, et al.
Publicado: (2017)

An epidemiological analysis of the burden of chronic thromboembolic pulmonary hypertension in the USA, Europe and Japan
por: Gall, Henning, et al.
Publicado: (2017)

CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2016)

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease
por: Wiedenroth, Christoph B., et al.
Publicado: (2017)

Effects of exercise training on pulmonary hemodynamics, functional capacity and inflammation in pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Riociguat dose titration in patients with chronic thromboembolic pulmonary hypertension (CTEPH) or pulmonary arterial hypertension (PAH)
por: Ghofrani, Hossein A, et al.
Publicado: (2009)

Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020)

Long-term effects of intravenous iloprost in patients with idiopathic pulmonary arterial hypertension deteriorating on non-parenteral therapy
por: Knudsen, Lars, et al.
Publicado: (2011)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
por: Marra, Alberto M., et al.
Publicado: (2018)

Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study
por: Richter, Manuel J., et al.
Publicado: (2019)

Impact of SARS-CoV-2 pandemic on pulmonary hypertension out-patient clinics in Germany: a multi-centre study
por: Yogeswaran, Athiththan, et al.
Publicado: (2020)

COVID-19 in lung transplant recipients—Risk prediction and outcomes
por: Kamp, Jan C., et al.
Publicado: (2021)

Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel J., et al.
Publicado: (2017)

Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Shifting Instead of Drifting – Improving Attentional Performance by Means of the Attention Training Technique
por: Barth, Vincent, et al.
Publicado: (2019)

Prevalence of Child Maltreatment in Adults With Congenital Heart Disease and Its Relationship With Psychological Well-Being, Health Behavior, and Current Cardiac Function
por: Proskynitopoulos, Phileas J., et al.
Publicado: (2021)

Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension
por: Richter, Manuel Jonas, et al.
Publicado: (2016)

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Humbert, Marc, et al.
Publicado: (2019)

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
por: Kramm, Thorsten, et al.
Publicado: (2018)

Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study
por: Gall, Henning, et al.
Publicado: (2016)

Behavioral pathway to a broken heart: The link between adverse childhood experiences, depression, physical exercise and cardiovascular health
por: Bertele, Sebastian, et al.
Publicado: (2022)

Impact of relationship status on psychological parameters in adults with congenital heart disease
por: Stapel, Britta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_24gcei46gpi3gpfmdqk7c8bi7l